Clinical Trial

Chongqing Diabetes Registry Study

Name: Chongqing Diabetes Registry Study — clinical trial record (NCT03692884)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CDR

Recruiting

View on ClinicalTrials.gov →

Summary

To investigate the risk factors and biomarkers of the microvascular disease，macrovascular disease and neuropathy in patients with diabetes.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2018-09-30; most recent amendment 2023-09-04.

Trial Details

NCT Number	NCT03692884
Lead Sponsor	Chongqing Medical University
Conditions	Diabetes Mellitus
Enrollment	5,000 participants
Start Date	2018-07-01
Primary Completion	2030-07-01 (estimated)
Study Completion	2030-07-01 (estimated)
Updated on ClinicalTrials.gov	2023-09-06